Učitavanje...
The histone H2B ubiquitin ligase RNF40 is required for HER2-driven mammary tumorigenesis
The HER2-positive breast cancer subtype (HER2(+)-BC) displays a particularly aggressive behavior. Anti-HER2 therapies have significantly improved the survival of patients with HER2(+)-BC. However, a large number of patients become refractory to current targeted therapies, necessitating the developme...
Spremljeno u:
| Izdano u: | Cell Death Dis |
|---|---|
| Glavni autori: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7568723/ https://ncbi.nlm.nih.gov/pubmed/33070155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-03081-w |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|